DUBLIN–(BUSINESS WIRE)–The “COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.
The global COVID-19 diagnostics market size reached US$ 94.5 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 32.1 Billion by 2027.
Companies Mentioned
Abbott Laboratories
Becton Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
F. Hoffman-La Roche Ltd. (Roche Holding AG)
Luminex Corporation
PerkinElmer Inc.
Quest Diagnostics Incorporated
Robert Bosch GmbH
Seegene Inc.
Siemens Aktiengesellschaft
Thermo Fisher Scientific Inc.
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth.
Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global COVID-19 diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, sample type, test type, mode and end use.
Breakup by Product Type:
Reagents and Kits
Instruments
Others
Breakup by Sample Type:
Nasopharyngeal Swabs
Oropharyngeal Swabs
Nasal Swabs
Blood
Others
Breakup by Test Type:
Molecular (RT-PCR) Testing
Antigen-based Testing
Antibody (Serology) Testing
Others
Breakup by Mode:
Point-of-Care (PoC)
Non-Point-of-Care (Non-PoC)
Breakup by End Use:
Laboratories
Hospitals
Diagnostic Centers and Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Key Questions Answered in This Report:
How has the global COVID-19 diagnostics market performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the sample type?
What is the breakup of the market based on the test type?
What is the breakup of the market based on the mode?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global COVID-19 diagnostics market and who are the key players?
What is the degree of competition in the industry?
For more information about this report visit https://www.researchandmarkets.com/r/dtkoj9
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900